Stock Scorecard
Stock Summary for Enveric Biosciences Inc (ENVB) - $0.35 as of 11/21/2024 12:04:42 AM EST
Total Score
14 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for ENVB
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ENVB
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ENVB
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ENVB
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ENVB (25 out of 90)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 10 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for ENVB
Financial Details for ENVB
Company Overview |
|
|---|---|
| Ticker | ENVB |
| Company Name | Enveric Biosciences Inc |
| Country | USA |
| Description | Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida. |
| Sector Name | MANUFACTURING |
| Industry Name | SEMICONDUCTORS & RELATED DEVICES |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 0.35 |
| Price 4 Years Ago | 74.00 |
| Last Day Price Updated | 11/21/2024 12:04:42 AM EST |
| Last Day Volume | 56,079 |
| Average Daily Volume | 983,030 |
| 52-Week High | 1.90 |
| 52-Week Low | 0.33 |
| Last Price to 52 Week Low | 6.06% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 52.73 |
| Sector PE | 38.01 |
| 5-Year Average PE | -3.48 |
| Free Cash Flow Ratio | 1.13 |
| Industry Free Cash Flow Ratio | 19.97 |
| Sector Free Cash Flow Ratio | 48.04 |
| Current Ratio Most Recent Quarter | 5.17 |
| Total Cash Per Share | 0.31 |
| Book Value Per Share Most Recent Quarter | 0.71 |
| Price to Book Ratio | 0.89 |
| Industry Price to Book Ratio | 5.20 |
| Sector Price to Book Ratio | 4.56 |
| Price to Sales Ratio Twelve Trailing Months | 0.08 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.53 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.42 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 9,944,900 |
| Market Capitalization | 3,480,715 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/23/2008 |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 18,489.50 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | 0.00% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 6.39% |
| Reported EPS 12 Trailing Months | -2.42 |
| Reported EPS Past Year | -0.91 |
| Reported EPS Prior Year | -20.59 |
| Net Income Twelve Trailing Months | -9,856,277 |
| Net Income Past Year | -17,291,732 |
| Net Income Prior Year | -18,471,333 |
| Quarterly Revenue Growth YOY | -7.30% |
| 5-Year Revenue Growth | -82.09% |
| Operating Margin Twelve Trailing Months | 0.00 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,111,683 |
| Total Cash Past Year | 2,287,977 |
| Total Cash Prior Year | 17,723,884 |
| Net Cash Position Most Recent Quarter | 3,111,683 |
| Net Cash Position Past Year | 2,287,977 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 1,956,336 |
| Total Stockholder Equity Prior Year | 14,671,924 |
| Total Stockholder Equity Most Recent Quarter | 3,951,150 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -8,165,629 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.82 |
| Free Cash Flow Past Year | -14,099,591 |
| Free Cash Flow Prior Year | -17,730,888 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.03 |
| MACD Signal | -0.01 |
| 20-Day Bollinger Lower Band | 0.37 |
| 20-Day Bollinger Middle Band | 0.48 |
| 20-Day Bollinger Upper Band | 0.59 |
| Beta | 0.47 |
| RSI | 30.92 |
| 50-Day SMA | 4.80 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 33.42 |
System |
|
| Modified | 11/21/2024 12:05:28 AM EST |